IRadimed Corporation (IRMD)
USD 51.36
(-4.18%)
USD 51.36
(-4.18%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 20.03 Million USD | 28.21% |
| 2022 | 15.62 Million USD | 59.18% |
| 2021 | 9.81 Million USD | 1398.48% |
| 2020 | -756.09 Thousand USD | -108.74% |
| 2019 | 8.64 Million USD | 44.03% |
| 2018 | 6 Million USD | 367.22% |
| 2017 | 1.28 Million USD | -88.23% |
| 2016 | 10.92 Million USD | -5.15% |
| 2015 | 11.51 Million USD | 275.52% |
| 2014 | 3.06 Million USD | 10.0% |
| 2013 | 2.78 Million USD | 95.64% |
| 2012 | 1.42 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 5.62 Million USD | 18.51% |
| 2024 Q1 | 4.74 Million USD | -7.97% |
| 2024 Q3 | 5.78 Million USD | 2.88% |
| 2023 Q2 | 4.96 Million USD | 23.85% |
| 2023 FY | 20.03 Million USD | 28.21% |
| 2023 Q1 | 4 Million USD | -5.8% |
| 2023 Q4 | 5.15 Million USD | -12.62% |
| 2023 Q3 | 5.9 Million USD | 18.99% |
| 2022 Q2 | 4.16 Million USD | 35.5% |
| 2022 Q1 | 3.07 Million USD | -1.11% |
| 2022 FY | 15.62 Million USD | 59.18% |
| 2022 Q4 | 4.25 Million USD | 2.94% |
| 2022 Q3 | 4.13 Million USD | -0.82% |
| 2021 Q1 | 1.77 Million USD | 172.95% |
| 2021 Q2 | 1.84 Million USD | 3.78% |
| 2021 FY | 9.81 Million USD | 1398.48% |
| 2021 Q3 | 3.08 Million USD | 67.38% |
| 2021 Q4 | 3.1 Million USD | 0.73% |
| 2020 Q3 | 784.75 Thousand USD | 126.79% |
| 2020 Q4 | 651.02 Thousand USD | -17.04% |
| 2020 FY | -756.09 Thousand USD | -108.74% |
| 2020 Q1 | 737.23 Thousand USD | -67.07% |
| 2020 Q2 | -2.92 Million USD | -497.31% |
| 2019 FY | 8.64 Million USD | 44.03% |
| 2019 Q1 | 1.51 Million USD | -15.56% |
| 2019 Q4 | 2.23 Million USD | -11.11% |
| 2019 Q3 | 2.51 Million USD | 6.02% |
| 2019 Q2 | 2.37 Million USD | 56.94% |
| 2018 Q4 | 1.79 Million USD | 23.81% |
| 2018 Q2 | 1.67 Million USD | 54.09% |
| 2018 Q1 | 1.08 Million USD | 8.76% |
| 2018 FY | 6 Million USD | 367.22% |
| 2018 Q3 | 1.44 Million USD | -13.57% |
| 2017 Q2 | 327.57 Thousand USD | 237.42% |
| 2017 Q4 | 999.75 Thousand USD | 409.92% |
| 2017 FY | 1.28 Million USD | -88.23% |
| 2017 Q1 | -238.38 Thousand USD | -115.84% |
| 2017 Q3 | 196.06 Thousand USD | -40.15% |
| 2016 Q1 | 3.48 Million USD | 3.85% |
| 2016 FY | 10.92 Million USD | -5.15% |
| 2016 Q4 | 1.5 Million USD | -41.96% |
| 2016 Q3 | 2.59 Million USD | -22.35% |
| 2016 Q2 | 3.34 Million USD | -4.06% |
| 2015 Q3 | 3.2 Million USD | 18.9% |
| 2015 Q2 | 2.69 Million USD | 18.95% |
| 2015 Q1 | 2.26 Million USD | 904.77% |
| 2015 FY | 11.51 Million USD | 275.52% |
| 2015 Q4 | 3.35 Million USD | 4.66% |
| 2014 FY | 3.06 Million USD | 10.0% |
| 2014 Q4 | 225.37 Thousand USD | -44.53% |
| 2014 Q1 | 824.08 Thousand USD | 14.0% |
| 2014 Q2 | 1.61 Million USD | 95.38% |
| 2014 Q3 | 406.3 Thousand USD | -74.77% |
| 2013 FY | 2.78 Million USD | 95.64% |
| 2013 Q2 | 779.69 Thousand USD | -16.06% |
| 2013 Q4 | 722.85 Thousand USD | 103.14% |
| 2013 Q3 | 355.84 Thousand USD | -54.36% |
| 2013 Q1 | 928.83 Thousand USD | 0.0% |
| 2012 FY | 1.42 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 239.513% |
| Cerus Corporation | -30.05 Million USD | 166.667% |
| OrthoPediatrics Corp. | -25.76 Million USD | 177.759% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 288.634% |
| Talis Biomedical Corporation | -66.81 Million USD | 129.986% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 215.839% |
| Inogen, Inc. | -109.38 Million USD | 118.316% |
| Spectral AI, Inc. | -12.98 Million USD | 254.309% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 132.011% |
| CVRx, Inc. | -43.1 Million USD | 146.483% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 667.898% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 261.212% |
| Orthofix Medical Inc. | -139.11 Million USD | 114.403% |
| Venus Concept Inc. | -28.3 Million USD | 170.774% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 137.083% |
| Bioventus Inc. | -81.72 Million USD | 124.516% |
| BrainsWay Ltd. | -4.92 Million USD | 506.646% |
| Envoy Medical, Inc. | -18.37 Million USD | 209.06% |
| electroCore, Inc. | -18.8 Million USD | 206.543% |
| IceCure Medical Ltd | -15.57 Million USD | 228.63% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 141.326% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 216.026% |
| MaxCyte, Inc. | -48.29 Million USD | 141.482% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 267.587% |
| Nexalin Technology, Inc. | -5.69 Million USD | 451.728% |
| PAVmed Inc | -68.79 Million USD | 129.123% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 135.421% |
| RxSight, Inc. | -50.08 Million USD | 140.003% |
| Sight Sciences, Inc. | -57.27 Million USD | 134.982% |
| SI-BONE, Inc. | -46.93 Million USD | 142.691% |
| TELA Bio, Inc. | -44.07 Million USD | 145.458% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 137.0% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 138.958% |
| LivaNova PLC | -68.49 Million USD | 129.25% |
| 908 Devices Inc. | -42.75 Million USD | 146.858% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 111.555% |
| Nemaura Medical Inc. | -9.59 Million USD | 308.806% |
| NeuroPace, Inc. | -27.17 Million USD | 173.73% |
| LENSAR, Inc. | -12.22 Million USD | 263.836% |
| Apyx Medical Corporation | -17.25 Million USD | 216.087% |
| Cutera, Inc. | -156.23 Million USD | 112.824% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 332.862% |
| BioSig Technologies, Inc. | -28.51 Million USD | 170.27% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 122.861% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 189.261% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 82.035% |
| Axonics, Inc. | -26.05 Million USD | 176.891% |
| Outset Medical, Inc. | -169.77 Million USD | 111.802% |
| IRIDEX Corporation | -10 Million USD | 300.214% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 118.353% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 343.001% |
| INVO Bioscience, Inc. | -6.76 Million USD | 396.069% |
| Telesis Bio, Inc. | -35.15 Million USD | 157.0% |
| Viemed Healthcare, Inc. | 14.33 Million USD | -39.815% |
| Varex Imaging Corporation | 32.1 Million USD | 37.584% |
| Quipt Home Medical Corp. | 3.91 Million USD | -411.239% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 265.132% |
| Pulmonx Corporation | -61.93 Million USD | 132.349% |
| Dynatronics Corporation | -2.27 Million USD | 981.436% |
| Modular Medical, Inc. | -17.52 Million USD | 214.299% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 236.864% |
| Semler Scientific, Inc. | 22.25 Million USD | 9.977% |
| InMode Ltd. | 195.66 Million USD | 89.76% |
| Bruker Corporation | 436.9 Million USD | 95.414% |
| Cytosorbents Corporation | -31.2 Million USD | 164.197% |
| DexCom, Inc. | 597.7 Million USD | 96.648% |
| Align Technology, Inc. | 643.33 Million USD | 96.886% |
| Viveve Medical, Inc. | -21.55 Million USD | 192.959% |
| ZimVie Inc. | -30.93 Million USD | 164.758% |
| Movano Inc. | -29.69 Million USD | 167.482% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 171.954% |
| Nexalin Technology, Inc. | -5.69 Million USD | 451.728% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 667.898% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 108.59% |
| Profound Medical Corp. | -28.61 Million USD | 170.015% |
| Insulet Corporation | 220 Million USD | 90.893% |
| enVVeno Medical Corporation | -25.23 Million USD | 179.386% |
| Surmodics, Inc. | -5.64 Million USD | 454.924% |
| iCAD, Inc. | -7.68 Million USD | 360.573% |
| Nuwellis, Inc. | -17.63 Million USD | 213.644% |
| Biotricity, Inc. | -8.82 Million USD | 326.947% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 116.008% |
| Aethlon Medical, Inc. | -12.63 Million USD | 258.551% |
| InspireMD, Inc. | -21.14 Million USD | 194.762% |
| PAVmed Inc. | -68.79 Million USD | 129.123% |
| BIOLASE, Inc. | -17.93 Million USD | 211.699% |
| Beyond Air, Inc. | -63 Million USD | 131.799% |
| FONAR Corporation | 16.53 Million USD | -21.167% |
| AxoGen, Inc. | -21.46 Million USD | 193.353% |
| Vivani Medical, Inc. | -26.96 Million USD | 174.302% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | -11.055% |
| Inari Medical, Inc. | -14.03 Million USD | 242.784% |
| UFP Technologies, Inc. | 57.66 Million USD | 65.255% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 506.597% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 417.732% |
| Tenon Medical, Inc. | -15.72 Million USD | 227.395% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 368.069% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 146.915% |
| AdaptHealth Corp. | -598.4 Million USD | 103.348% |
| Sintx Technologies, Inc. | -13.35 Million USD | 249.988% |
| NanoVibronix, Inc. | -3.43 Million USD | 683.104% |
| Quanterix Corporation | -49.7 Million USD | 140.312% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 265.132% |
| Sensus Healthcare, Inc. | -382 Thousand USD | 5344.884% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 105.99% |
| TransMedics Group, Inc. | -28.72 Million USD | 169.744% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 184.853% |
| NeuroMetrix, Inc. | -7.15 Million USD | 380.157% |
| Hyperfine, Inc. | -48.11 Million USD | 141.641% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 130.811% |
| Biomerica, Inc. | -6.36 Million USD | 414.677% |
| Bone Biologics Corporation | -9.42 Million USD | 312.503% |
| AVITA Medical, Inc. | -40.4 Million USD | 149.59% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 294.307% |
| Silk Road Medical, Inc | -59.27 Million USD | 133.803% |